Exforge HCT approved for hypertension
The FDA has approved Novartis' Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an angiotensin receptor blocker, and a diuretic, for the treatment of hypertension.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.